Dexcom | DXCM - 现金及等价物



金融业
股票价格
USD
资产
USD 6.46B
现金及等价物
USD 1.11B
销售成本
USD 478.4M
流动资产
USD 4.09B
流动负债
USD 2.36B
债务
USD 1.24B
EBIT
USD 318.3M
EBITDA
USD 364.5M
员工
10.3K
EPS每股收益
USD 0.7
股本和储备
USD 2.62B
销售毛利
USD 750.3M
债务利息支出
USD 3.1M
利息收入
USD 19.5M
贷款资金
USD 1.3B
市值
USD 34.79B
净收入
USD 249.1M
营业费用
USD 990.1M
营业利润
USD 318.3M
普通股股本
USD 377.4M
PE价格收益
24.61
税前利润
USD 269.5M
销售收入
USD 1.31B
销售和管理费用
USD 358.7M
股票
USD 726.4M
贸易债权人
USD 2.08B
应收帐款人
USD 1.27B


现金及等价物 更改 日
Abbott USD 6.8B 1.72B 2026-03
Align Technology USD 1.1B 42.76M 2026-06
AtriCure USD 167.79M 21.62M 2026-06
Baxter International USD 2.15B 133M 2026-06
Becton, Dickinson and Co. USD 708M 105M 2026-06
Boston Scientific USD 539M 914M 2026-06
Cooper Companies USD 124.9M 14.3M 2025-12
Dexcom USD 1.1B 13.2M 2026-06
Edwards Lifesciences USD 2.9B 500M 2026-06
Globus Medical USD 507.74M 53.2M 2026-06
Inogen USD 106.48M 2.79M 2025-09
Insulet USD 534.9M 54.5M 2026-06
Integra LifeSciences USD 214.42M 22.39M 2026-06
J&J USD 20.42B 1.27B 2026-06
Medtronic USD 1.15B 135M 2025-12
Merit Medical Systems USD 448.7M 39.38M 2026-06
Roche Holding CHF 7.55B 579M 2025-06
Solventum Corp USD 403M 158M 2026-06
Stryker USD 3.39B 513M 2026-06
Tandem Diabetes Care USD 62.82M 116.51M 2026-06
Teleflex USD 300.16M 9.25M 2026-06
West Pharmaceutical Services USD 435.8M 85.6M 2026-06
Zimmer Biomet Holdings USD 410M 14.2M 2026-06